These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32529740)

  • 1. Atrase B, a novel metalloprotease with anti-complement and anti-coagulant activity, significantly delays discordant cardiac xenograft rejection.
    Fu C; Shi L; Huang X; Feng H; Tan X; Chen S; Zhu L; Sun Q; Chen G
    Xenotransplantation; 2020 Sep; 27(5):e12616. PubMed ID: 32529740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet aggregation and blood coagulation by a P-III class metalloproteinase purified from Naja atra venom.
    Sun QY; Wang CE; Li YN; Bao J
    Toxicon; 2020 Nov; 187():223-231. PubMed ID: 32971099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification, cloning and characterization of a metalloproteinase from Naja atra venom.
    Sun QY; Bao J
    Toxicon; 2010 Dec; 56(8):1459-69. PubMed ID: 20837040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolongation of cardiac xenograft survival by depletion of complement.
    Leventhal JR; Dalmasso AP; Cromwell JW; Platt JL; Manivel CJ; Bolman RM; Matas AJ
    Transplantation; 1993 Apr; 55(4):857-65; discussion 865-6. PubMed ID: 8475561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cobra venom P-III class metalloproteinase atrase A induces inflammatory response and cell apoptosis in endothelial cells via its metalloproteinase domain.
    Wei Y; Lu QY; Zhong XJ; Guo L; Zeng FY; Sun QY
    Toxicon; 2023 Aug; 232():107210. PubMed ID: 37393957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival.
    Candinas D; Lesnikoski BA; Robson SC; Miyatake T; Scesney SM; Marsh HC; Ryan US; Dalmasso AP; Hancock WW; Bach FH
    Transplantation; 1996 Aug; 62(3):336-42. PubMed ID: 8779679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
    Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
    Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model.
    Leventhal JR; Matas AJ; Sun LH; Reif S; Bolman RM; Dalmasso AP; Platt JL
    Transplantation; 1993 Jul; 56(1):1-8. PubMed ID: 8333031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of xenoreactive antibody and B cell depletion on hyperacute rejection of guinea pig-to-rat cardiac xenografts.
    Pruitt SK; Baldwin WM; Barth RN; Sanfilippo F
    Transplantation; 1993 Dec; 56(6):1318-24. PubMed ID: 8278996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection.
    Pruitt SK; Baldwin WM; Marsh HC; Lin SS; Yeh CG; Bollinger RR
    Transplantation; 1991 Nov; 52(5):868-73. PubMed ID: 1949173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of leflunomide and deoxyspergualin in the guinea pig-->rat cardiac model of delayed xenograft rejection: suppression of B cell and C-C chemokine responses but not induction of macrophage lectin.
    Hancock WW; Miyatake T; Koyamada N; Kut JP; Soares M; Russell ME; Bach FH; Sayegh MH
    Transplantation; 1997 Sep; 64(5):696-704. PubMed ID: 9311705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement-fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection.
    Miyatake T; Sato K; Takigami K; Koyamada N; Hancock WW; Bazin H; Latinne D; Bach FH; Soares MP
    J Immunol; 1998 Apr; 160(8):4114-23. PubMed ID: 9558123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial cell protection and complement inhibition in xenotransplantation: a novel in vitro model using whole blood.
    Banz Y; Cung T; Korchagina EY; Bovin NV; Haeberli A; Rieben R
    Xenotransplantation; 2005 Nov; 12(6):434-43. PubMed ID: 16202066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CD11b/CD18 mediated neutrophil adhesion in complement deficient xenograft recipients.
    Jakobs FM; Davis EA; Qian Z; Liu DY; Baldwin WM; Sanfilippo F
    Clin Transplant; 1997 Oct; 11(5 Pt 2):516-21. PubMed ID: 9361953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet integrin GPIIbIIIa prolongs survival of discordant cardiac xenografts.
    Candinas D; Lesnikoski BA; Hancock WW; Otsu I; Koyamada N; Dalmasso AP; Robson SC; Bach FH
    Transplantation; 1996 Jul; 62(1):1-5. PubMed ID: 8693522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic suppression of pre-perfusion of donor livers with recipient serum and cobra venom factor treatment on hyperacute rejection following liver xenotransplantation.
    Zhu B; Tong C; Guo W; Pu R; Zhang G; Wang L; Li M
    Acta Cir Bras; 2012 May; 27(5):301-5. PubMed ID: 22666742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A soluble chimeric inhibitor of C3 and C5 convertases, complement activation blocker-2, prolongs graft survival in pig-to-rhesus monkey heart transplantation.
    Salerno CT; Kulick DM; Yeh CG; Guzman-Paz M; Higgins PJ; Benson BA; Park SJ; Shumway SJ; Bolman RM; Dalmasso AP
    Xenotransplantation; 2002 Mar; 9(2):125-34. PubMed ID: 11897005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection.
    Blakely ML; Van der Werf WJ; Berndt MC; Dalmasso AP; Bach FH; Hancock WW
    Transplantation; 1994 Nov; 58(10):1059-66. PubMed ID: 7974711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolongation of discordant renal xenograft survival by depletion of complement. Comparative effects of systemically administered cobra venom factor and soluble complement receptor type 1 in a guinea-pig to rat model.
    Chrupcala M; Pomer S; Staehler G; Waldherr R; Kirschfink C
    Transpl Int; 1994; 7 Suppl 1():S650-3. PubMed ID: 11271331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrase A, a P-III class metalloproteinase purified from cobra venom, exhibits potent anticoagulant activity by inhibiting coagulation pathway and activating the fibrinolytic system.
    Zhong XJ; Wang CE; Li YN; Zhang QY; Sun QY
    Heliyon; 2024 May; 10(10):e30969. PubMed ID: 38813202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.